Antonio Rosato Laboratory (@AntonioRosatoL1) / Twitter
PDF) Wet sol–gel derived silica for controlled release of proteins | margherita morpurgo - Academia.edu
IMPULSO ALLA RICERCA: PRESENTATE LE ATTIVITÀ DEL CONSORZIO REGIONALE CORIS, DI CUI IOV-IRCCS È MEMBRO CONSORZIATO - Istituto Oncologico Veneto
Department of Economics and Management "Marco Fanno" | Università di Padova
Antonio ROSATO | University of Padova, Padova | UNIPD | Department of Surgery, Oncology and Gastroenterology DISCOG
Survivin Expression and Prognostic Significance in Pediatric Malignant Peripheral Nerve Sheath Tumors (MPNST)
Premio nazionale dell'innovazione a Catania: Hadjuvant si aggiudica due menzioni speciali | Università di Padova
Lions Club Padova Certosa - Home | Facebook
Predicting Tumor Outcome following Cancer Vaccination by Monitoring Quantitative and Qualitative CD8+ T Cell Parameters | The Journal of Immunology
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells | Journal for ImmunoTherapy of Cancer
Individual Analysis of Mice Vaccinated against a Weakly Immunogenic Self Tumor-Specific Antigen Reveals a Correlation between CD8 T Cell Response and Antitumor Efficacy | The Journal of Immunology
Intervista ad Antonio Rosato e Giuseppe Astori | ATMP Forum
Full article: Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies
PDF) Neutralizing Antibody Responses to SARS-CoV-2 in Recovered COVID-19 Patients Are Variable and Correlate With Disease Severity and Receptor-Binding Domain Recognition
Loop | Michelangelo Cordenonsi
Antonio ROSATO | University of Padova, Padova | UNIPD | Department of Surgery, Oncology and Gastroenterology DISCOG
Prof. Antonio Rosato | LMCome
Antonio Parbonetti - Istituto di Ricerca Pediatrica Città della Speranza
Novel Types of Carborane‐Carrier Hyaluronan Derivatives via “Click Chemistry” - Di Meo - 2008 - Macromolecular Bioscience - Wiley Online Library
Trattamento dei linfomi non Hodgkin, scoperta a Padova la rivoluzionaria terapia
Premio nazionale dell'innovazione a Catania: Hadjuvant si aggiuca due menzioni speciali
Lo studio dello Iov: «Così armiamo le cellule killer contro il cancro» - Il Mattino di Padova Padova
PDF) Biodistribution imaging of a paclitaxel-hyaluronan bioconjugate | L. Melendez-Alafort - Academia.edu
Prevenzione, beneficenza e spettacolo: tutto questo è "Ipercity è Sociale"
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells | Journal for ImmunoTherapy of Cancer
Anatomical Theatre of Padua, Bo Palace, University of Padua | HiSoUR - Hi So You Are
Antonio Rosato Laboratory (@AntonioRosatoL1) / Twitter
